Staber, Philipp B., Herling, Marco, Bellido, Mar, Jacobsen, Eric D., Davids, Matthew S., Kadia, Tapan Mahendra, Shustov, Andrei, Tournilhac, Olivier, Bachy, Emmanuel, Zaja, Francesco ORCID: 0000-0003-3995-8817, Porkka, Kimmo ORCID: 0000-0003-4112-5902, Hoermann, Gregor ORCID: 0000-0002-7374-4380, Simonitsch-Klupp, Ingrid, Haferlach, Claudia, Kubicek, Stefan ORCID: 0000-0003-0855-8343, Mayerhoefer, Marius E., Hopfinger, Georg, Jaeger, Ulrich and Dearden, Claire (2019). Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia. Blood, 134 (14). S. 1132 - 1144. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Full text not available from this repository.

Abstract

T-cell prolymphocytic leukemia (T-PLL) is a rare, mature T-cell neoplasm with a heterogeneous clinical course. With the advent of novel treatment options that will potentially change the management of patients with T-PLL, it has become necessary to produce consensus guidelines for the design and conduct of clinical trials. The T-PLL International Study group (TPLL-ISG) set out to define standardized criteria for diagnosis, treatment indication, and evaluation of response. These criteria will facilitate comparison of results from clinical trials in T-PLL, and will thus support clinical decision making, as well as the approval of new therapeutics by healthcare authorities.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Staber, Philipp B.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Herling, MarcoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bellido, MarUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Jacobsen, Eric D.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Davids, Matthew S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kadia, Tapan MahendraUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Shustov, AndreiUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Tournilhac, OlivierUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bachy, EmmanuelUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Zaja, FrancescoUNSPECIFIEDorcid.org/0000-0003-3995-8817UNSPECIFIED
Porkka, KimmoUNSPECIFIEDorcid.org/0000-0003-4112-5902UNSPECIFIED
Hoermann, GregorUNSPECIFIEDorcid.org/0000-0002-7374-4380UNSPECIFIED
Simonitsch-Klupp, IngridUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Haferlach, ClaudiaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kubicek, StefanUNSPECIFIEDorcid.org/0000-0003-0855-8343UNSPECIFIED
Mayerhoefer, Marius E.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hopfinger, GeorgUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Jaeger, UlrichUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Dearden, ClaireUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-131412
DOI: 10.1182/blood.2019000402
Journal or Publication Title: Blood
Volume: 134
Number: 14
Page Range: S. 1132 - 1144
Date: 2019
Publisher: AMER SOC HEMATOLOGY
Place of Publication: WASHINGTON
ISSN: 1528-0020
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
CHRONIC LYMPHOCYTIC-LEUKEMIA; CHROMOSOMAL IMBALANCES; MUTATIONS; GENE; MALIGNANCIES; ALEMTUZUMAB; EXPRESSION; GUIDELINES; JAK3; TRANSPLANTATIONMultiple languages
HematologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/13141

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item